| |
|
|
|
vTv Therapeutics Inc.  
|
|
1.74 0.02 (0.01%) |
03-22 16:00 |
|
Open: |
1.75 |
Pre close: |
1.72 |
Target:
|
2.65
|
|
High: |
1.78 |
Low: |
1.71 |
Resistance:
|
2.27
2.62
|
|
Volume: |
291,360 |
Market Cap: |
81M |
Support:
|
1.71
1.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.85
 |
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
2.16 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
2.26 |
Stochastic Oscillator |
%K(14,3):
|
2.34 |
|
MA(250): |
1.97 |
%D(3): |
6.60 |
|
Average Volume(K) |
3-Month: |
243760
|
52-Week |
High:
|
6.09 |
|
10-Days: |
50025 |
Low: |
0.65 |
|
RSI |
RSI(14):
|
30.15  |
Change(%): |
-60.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.750 |
Return on Equity (ttm) |
7.4 |
Shares Out. (M) |
46.70 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-47.4 |
Shares Float (M) |
46.58 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
1840.8 |
% Held by Institutions |
11.30 |
|
Forward EPS |
-1.728 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.32 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.86 |
P/S |
41081400.00 |
|
Operating Margin |
-159.43 |
Levered Free Cash Flow
(M) |
-15.81 |
P/CF |
-3.03 |
|
|
|
|
|
|
